| A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects (NCT05679258) | Shanghai Henlius Biotech | 2023-01-31 |
| Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL (NCT05679895) | OneChain Immunotherapeutics | 2023-01-31 |
| Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma (NCT05564806) | Eucure (Beijing) Biopharma Co., Ltd | 2023-01-31 |
| A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults (NCT05693272) | University of Saskatchewan | 2023-01-31 |
| A HR20031 FE Study on Healthy Subjects (NCT05692934) | Shandong Suncadia Medicine Co., Ltd. | 2023-01-31 |
| Vancomycin Study in Multiple Sclerosis (MS) (NCT05539729) | Icahn School of Medicine at Mount Sinai | 2023-01-31 |
| A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors (NCT05650242) | Shandong Boan Biotechnology Co., Ltd | 2023-01-31 |
| Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma (NCT05665725) | Timothy Voorhees | 2023-01-31 |
| A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia (NCT05520567) | Astellas Pharma Global Development, Inc. | 2023-01-31 |
| Mesenchymal Stem Cells for Age-Related Frailty (NCT05284604) | VA Office of Research and Development | 2023-01-31 |
| Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients (NCT06077214) | Virginia Commonwealth University | 2023-01-31 |
| A HR20031 BE Study on Healthy Subjects (NCT05682495) | Shandong Suncadia Medicine Co., Ltd. | 2023-01-31 |
| The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects (NCT05702983) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2023-01-31 |
| Schools Championing Safe South Africa (NCT05869864) | Brown University | 2023-01-31 |
| Mechanism of EGR2 in Allergic Rhinitis (NCT05724290) | Zu-xia Ma | 2023-01-30 |
| A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults (NCT05627258) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-01-30 |
| A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function (NCT05706623) | VectivBio AG | 2023-01-30 |
| A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL (NCT05658562) | Tanabe Pharma Corporation | 2023-01-30 |
| A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours (NCT05508334) | RemeGen Co., Ltd. | 2023-01-30 |
| Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC) (NCT04989218) | University of Alabama at Birmingham | 2023-01-30 |
| Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients (NCT05456243) | Mayo Clinic | 2023-01-30 |
| Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir (NCT05731843) | Atea Pharmaceuticals, Inc. | 2023-01-30 |
| Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients (NCT02133885) | University of Florida | 2023-01-30 |
| A Study to Assess NEU-723 in Healthy Participants (NCT05633745) | Neuron23 Inc. | 2023-01-30 |
| Safety Study of GMDTC Injection in Healthy Participants (NCT05908383) | Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd. | 2023-01-30 |
| Acetazolamide on REM OSA (NCT05589792) | Brigham and Women's Hospital | 2023-01-30 |
| Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer (NCT05617040) | Barinthus Biotherapeutics | 2023-01-30 |
| Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis (NCT05537025) | Arrowhead Pharmaceuticals | 2023-01-30 |
| Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function (NCT05724693) | Atea Pharmaceuticals, Inc. | 2023-01-30 |
| A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults (NCT05721287) | Sparian Biosciences, Inc | 2023-01-30 |
| A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer (NCT05609370) | BeiGene | 2023-01-29 |
| Phase 1b Study of DCR-AUD in Healthy Volunteers (NCT05845398) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2023-01-29 |
| Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection (NCT05741099) | Hebei Medical University | 2023-01-28 |
| An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions (NCT05667818) | Overseas Pharmaceuticals, Ltd. | 2023-01-28 |
| A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults (NCT05673889) | Pfizer | 2023-01-27 |
| Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index (NCT05524246) | Children's Hospital Medical Center, Cincinnati | 2023-01-27 |
| A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies (NCT05629689) | GE Healthcare | 2023-01-27 |
| Comparative Effects of Using Black Seed and Cumin Seed on BCP of Obese Grade I (NCT05770791) | Sehat Medical Complex | 2023-01-27 |
| Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies (NCT05270057) | Medical College of Wisconsin | 2023-01-26 |
| Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... (NCT05470491) | National Cancer Institute (NCI) | 2023-01-26 |
| NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors (NCT05528341) | Henan Medical University | 2023-01-26 |
| First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours (NCT05759923) | Molecure S.A. | 2023-01-26 |
| A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma (NCT05551936) | Vaishalee Kenkre | 2023-01-26 |
| PET Study of Repeated ASN51 in Healthy Volunteers (NCT05725005) | Asceneuron S.A. | 2023-01-26 |
| A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants (NCT05720494) | Jazz Pharmaceuticals | 2023-01-26 |
| Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma (NCT05455697) | University of Washington | 2023-01-26 |
| Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects (NCT05742984) | Cinclus Pharma Holding AB | 2023-01-26 |
| A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis (NCT05743010) | Jiangsu Yahong Meditech Co., Ltd aka Asieris | 2023-01-26 |
| Study to Assess SLN124 in Patients With Polycythemia Vera (NCT05499013) | Silence Therapeutics plc | 2023-01-26 |
| RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors (NCT04525014) | EpicentRx, Inc. | 2023-01-26 |
| Co-administration of CART22-65s and huCART19 for B-ALL (NCT05674175) | Stephan Grupp MD PhD | 2023-01-25 |
| To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination (NCT05737771) | Daewoong Pharmaceutical Co. LTD. | 2023-01-25 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD). (NCT05513950) | Chiesi Farmaceutici S.p.A. | 2023-01-25 |
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (NCT05703607) | Pfizer | 2023-01-25 |
| A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis (NCT05714072) | Memorial Sloan Kettering Cancer Center | 2023-01-25 |
| Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies (NCT05694364) | H. Lee Moffitt Cancer Center and Research Institute | 2023-01-25 |
| A Study of Milvexian in Healthy Adult Females (NCT05706753) | Janssen Pharmaceutica N.V., Belgium | 2023-01-25 |
| AMT-151 in Patients With Selected Advanced Solid Tumours (NCT05498597) | Multitude Therapeutics Inc. | 2023-01-25 |
| Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant (NCT05712265) | Corcept Therapeutics | 2023-01-24 |
| Use of Platelet Rich Plasma from Cord Blood Vs Placebo in the Treatment of Vulvar Lichen Sclerosus (NCT06661382) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2023-01-24 |
| Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer (NCT05712889) | Vincerx Pharma, Inc. | 2023-01-24 |
| CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia (NCT05168748) | Novartis Pharmaceuticals | 2023-01-24 |
| A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies (NCT05336409) | Century Therapeutics, Inc. | 2023-01-24 |
| A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 (NCT05514717) | Day One Biopharmaceuticals, Inc. | 2023-01-24 |
| Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. (NCT05276492) | University of Chicago | 2023-01-24 |
| Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer (NCT05563220) | Stemline Therapeutics, Inc. | 2023-01-24 |
| Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy (NCT05187429) | University of Melbourne | 2023-01-24 |
| Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors (NCT05642949) | Minghui Pharmaceutical Pty Ltd | 2023-01-23 |
| Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants. (NCT04915768) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-01-23 |
| A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma (NCT05590377) | Teva Branded Pharmaceutical Products R&D LLC | 2023-01-23 |
| Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma (NCT05256641) | Jonsson Comprehensive Cancer Center | 2023-01-23 |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age (NCT05701800) | ModernaTX, Inc. | 2023-01-23 |
| Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors (NCT05652855) | Minghui Pharmaceutical Pty Ltd | 2023-01-23 |
| Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT05677347) | GlaxoSmithKline | 2023-01-23 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects (NCT05735249) | Arisan Therapeutics, Inc. | 2023-01-23 |
| Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease (NCT05130983) | Direct Biologics, LLC | 2023-01-23 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas (NCT05619744) | Hoffmann-La Roche | 2023-01-23 |
| Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis (NCT05006430) | Prasun Kumar Jalal | 2023-01-21 |
| ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies (NCT05653271) | Acepodia Biotech, Inc. | 2023-01-21 |
| A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation in Healthy Adult Participants (MK-4482-011) (NCT06615869) | Merck Sharp & Dohme LLC | 2023-01-20 |
| COMPARISON OF WARFARIN AND RIVAROXABAN IN THE TREATMENT OF LOWER LIMB DEEP VENOUS THROMBOSIS (NCT07077954) | Children Hospital and Institute of Child Health, Lahore | 2023-01-20 |
| Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma (NCT05484622) | Institut de Recherches Internationales Servier | 2023-01-20 |
| Pharmacological Agents for Chronic Spinal Cord Injury (SCI) (NCT05708274) | Bronx VA Medical Center | 2023-01-20 |
| An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D (NCT05565248) | CRISPR Therapeutics AG | 2023-01-20 |
| Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants (NCT05696483) | Oligomerix, Inc | 2023-01-20 |
| Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors (NCT05693844) | Chinese PLA General Hospital | 2023-01-20 |
| Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy (NCT05918718) | Tehran University of Medical Sciences | 2023-01-20 |
| Creatine Supplementation and Resistance Training in Premenopausal Females (NCT05745870) | University of Idaho | 2023-01-20 |
| A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range (NCT05671653) | Pfizer | 2023-01-19 |
| The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy (NCT05688904) | Wright State University | 2023-01-19 |
| iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects (NCT05740280) | Cellivery Therapeutics, Inc. | 2023-01-19 |
| An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer (NCT05558904) | Jonsson Comprehensive Cancer Center | 2023-01-19 |
| Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma (NCT05440942) | Peter Hosein, MD | 2023-01-19 |
| Pilot Imaging Study of Leukemia (NCT03633955) | University of Oklahoma | 2023-01-19 |
| Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease (NCT05677633) | University of Nebraska | 2023-01-19 |
| Study to Evaluate the Food Effect of TP-05 in Healthy Participants (NCT05720364) | Tarsus Pharmaceuticals, Inc. | 2023-01-19 |
| Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers (NCT05732194) | Intra-Cellular Therapies, Inc. | 2023-01-18 |
| COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide (NCT05434689) | University of Alabama at Birmingham | 2023-01-18 |
| A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment (NCT05607173) | Sanofi | 2023-01-18 |
| A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer (NCT06232863) | Zhuhai Beihai Biotech Co., Ltd | 2023-01-18 |